Trident Lifeline touches roof on getting nod to acquire 51% stake in TLL Herbal

17 Jul 2023 Evaluate

Trident Lifeline is locked its upper circuit limit at Rs. 160.20, up by 26.70 points or 20.00% from its previous closing of Rs. 133.50 on the BSE.

The scrip opened at Rs. 146.00 and has touched a high and low of Rs. 160.20 and Rs. 146.00 respectively. So far 20400 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 179.95 on 24-Oct-2022 and a 52 week low of Rs. 102.75 on 11-Oct-2022.

Last one week high and low of the scrip stood at Rs. 160.20 and Rs. 131.00 respectively. The current market cap of the company is Rs. 153.51 crore.

The promoters holding in the company stood at 70.04%, while Institutions and Non-Institutions held 4.36% and 25.60% respectively.

Trident Lifeline has received approval for acquisition of majority stake (51%) in TLL Herbal from the existing shareholders of TLL Herbal, making it Subsidiary of the Company. The objective of acquisition is to expand the business towards new technologies by establishing a Research & Development cum production facility along with integration facility. The Board of Directors, at their meeting held on July 15, 2023, has transacted, approved the same. 

Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.

Trident Lifeline Share Price

303.20 -1.80 (-0.59%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×